Diagnosis, Biopsy, and the Genetic Blueprint
At a Glance
Ultrasound alone cannot confirm oligomeganephronia because it cannot count or measure individual filtering units. A kidney biopsy may show fewer but enlarged filtering clusters, while genetic testing may find an associated change; a negative result does not rule out OMN.
Confirming a diagnosis of oligomeganephronia (OMN) is a detailed process because the condition can be subtle on standard imaging. While an ultrasound may show slightly small or unusually bright kidneys, it cannot count the number of filtering units or measure their size [1][2]. For this reason, a kidney biopsy and genetic testing are often the tools doctors use to understand what is happening inside your child’s kidneys.
Why Ultrasound is Not Enough
A standard renal ultrasound is an excellent tool for looking at the shape and size of the kidneys, but OMN is a microscopic structural difference.
- Normal Size: Because the remaining filters (nephrons) grow so much larger to compensate, the overall kidney size may appear normal or only slightly reduced on an ultrasound, though size can vary [2][1].
- Hidden Details: Ultrasound cannot see individual nephrons. It can show if the kidney tissue looks “bright” (echogenic), which suggests scarring, but it cannot definitively confirm that OMN is the cause [3][4].
The Role of Kidney Biopsy
A kidney biopsy—where a tiny sample of tissue is removed and examined by a specialist called a pathologist—can provide a definitive structural diagnosis. However, your nephrologist must weigh the bleeding and anesthesia risks of a biopsy against the likely benefit, and it is not always clinically necessary. If performed, the pathologist looks for two specific “hallmarks” under a microscope:
- Reduced Density: There are far fewer glomeruli (the blood-filtering clusters) than there should be in the sample. This is often called paucity [5][2].
- Massive Enlargement: The glomeruli that are present are significantly larger than normal, a condition known as glomerulomegaly [2][6].
The pathologist may also look for signs of sclerosis (scarring) or tubular dilation, which tells them how much stress the kidneys have been under [2][5].
The Role of Genetics
There is no single “OMN gene.” Instead, OMN is considered a severe form of renal hypoplasia (underdeveloped kidneys), which can be associated with changes in several different genes that act as blueprints [7][8].
- PAX2: This is a notable gene linked to kidney-development disorders. Changes in PAX2 can also sometimes affect the eyes, so your doctor may recommend an eye exam if a pathogenic variant is found [1][9].
- PBX1: This gene is involved in early organ development. Changes here are often linked to a group of conditions called CAKUT (Congenital Anomalies of the Kidney and Urinary Tract) [10][4].
- Chromosome 4p Deletions: In some cases, syndromic disease like Wolf-Hirschhorn Syndrome, caused by a missing piece of Chromosome 4, may involve these features [3][11].
Genetic testing can help your team understand if the condition might affect other parts of the body. Keep in mind a negative test does not exclude OMN, and many children have no identified cause [9].
Your Completeness Checklist
When reviewing reports with your child’s medical team, these data points are often discussed. Note that a pathologist interprets these in context; measurements vary by age and sampling, so parents should not diagnose based on rigid cutoffs.
Pathology Report (Biopsy)
- [ ] Glomerular Density: Number of filters per square millimeter (e.g., OMN often shows less than 1.0/mm², depending on age) [5][2].
- [ ] Glomerular Diameter: The actual size in micrometers (μm) (e.g., OMN filters often exceed 210 μm) [5][2].
- [ ] FSGS Evidence: Presence of focal segmental glomerulosclerosis, which is a secondary pattern of scarring from injury [5][12].
- [ ] Tubular Status: Notes on “proximal tubular dilation” or “enlarged epithelial cells” [5][2].
Genetic Report
- [ ] Test Type: Whether they performed a targeted panel (looking at specific kidney genes), chromosomal microarray, or exome sequencing [12][9].
- [ ] Specific Variants: The exact name of any mutation found (e.g., in PAX2 or PBX1) [1][4].
- [ ] Classification: Whether the finding is “Pathogenic” (known to cause disease) or a “Variant of Uncertain Significance” (VUS). A VUS should not direct treatment without genetics interpretation [8].
Common questions in this guide
Can an ultrasound confirm oligomeganephronia?
What can a kidney biopsy show in oligomeganephronia?
Is a kidney biopsy always needed to diagnose OMN?
What genes or chromosome changes can be linked to oligomeganephronia?
What should parents look for in an OMN pathology or genetic report?
Why might a child with OMN need an eye exam?
Get notified when new evidence is published on Oligomeganephronia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
PAX2 Mutation-Related Oligomeganephronia in a Young Adult Patient.
Bitó L, Kalmár T, Maróti Z, et al.
Case reports in nephrology and dialysis 2020; (10(3)):163-173 doi:10.1159/000510841.
PMID: 33363218 - 2
Pathological and clinical characteristics of late-onset oligomeganephronia based on a histomorphometric study.
Ren YL, Li Y, Gao J, et al.
BMC nephrology 2023; (24(1)):54 doi:10.1186/s12882-023-03096-3.
PMID: 36922764 - 3
Oligonephronia and Wolf-Hirschhorn syndrome: A further observation.
Gatto A, Ferrara P, Leoni C, et al.
American journal of medical genetics. Part A 2018; (176(2)):409-414 doi:10.1002/ajmg.a.38554.
PMID: 29193639 - 4
A novel pathogenic variant c.262delA in PBX1 causing oligomeganephronia identified using whole-exome sequencing and a literature review.
Hu J, Yang H, Wang X, et al.
American journal of medical genetics. Part A 2023; (191(12)):2850-2855 doi:10.1002/ajmg.a.63364.
PMID: 37571997 - 5
Clinical and pathological investigation of oligomeganephronia.
Kitakado H, Horinouchi T, Masuda C, et al.
Pediatric nephrology (Berlin, Germany) 2023; (38(3)):757-762 doi:10.1007/s00467-022-05687-y.
PMID: 35861872 - 6
Oligomeganephronia with PAX2 gene deletion diagnosed at the third renal biopsy: a case report.
Yokoyama T, Sakumura N, Inoue N, et al.
Journal of nephrology 2024; (37(2)):495-499 doi:10.1007/s40620-023-01816-4.
PMID: 38060109 - 7
Renal Hypoplasia, From Grossly Insufficient to Not Quite Enough: Consideration for Expanded Concepts Based Upon the Author's Perspective With Historical Review.
Bonsib SM
Advances in anatomic pathology 2020; (27(5)):311-330 doi:10.1097/PAP.0000000000000269.
PMID: 32520748 - 8
PAX2 and CAKUT Phenotypes: Report on Two New Variants and a Review of Mutations from the Leiden Open Variation Database.
Negrisolo S, Benetti E
International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24044165.
PMID: 36835576 - 9
Diverse phenotypes in children with PAX2-related disorder.
Deng H, Zhang Y, Xiao H, et al.
Molecular genetics & genomic medicine 2019; (7(6)):e701 doi:10.1002/mgg3.701.
PMID: 31060108 - 10
Inherited intragenic PBX1 deletion: Expanding the phenotype.
Fitzgerald KK, Powell-Hamilton N, Shillingford AJ, et al.
American journal of medical genetics. Part A 2021; (185(1)):234-237 doi:10.1002/ajmg.a.61932.
PMID: 33098248 - 11
Renal Hypoplasia and Oligomeganephronia in a Fetus with Wolf-Hirschhorn Syndrome.
Bonasoni MP, Pati M, Shah K, et al.
Diagnostics (Basel, Switzerland) 2025; (15(21)) doi:10.3390/diagnostics15212687.
PMID: 41225980 - 12
Phenotype-Genotype Correlations in Three Different Cases of Adult-Onset Genetic Focal Segmental Glomerulosclerosis.
Kalmár T, Turkevi-Nagy S, Bitó L, et al.
International journal of molecular sciences 2023; (24(24)) doi:10.3390/ijms242417489.
PMID: 38139322
This page is for informational purposes only and does not constitute medical advice about a child’s oligomeganephronia. A pediatric nephrologist, pathologist, and genetics team should interpret biopsy and genetic results for your child.